Minimal Residual Disease Response at End of Induction and during Maintenance Correlates with Updated Outcome in the Phase III GALLIUM Study of Obinutuzumab- or Rituximab-Based Immunochemotherapy in Previously Untreated Follicular Lymphoma Patients

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology 》 |2018年第novaelatreatmentappr期| 共4页
• 作者

  Pott Christiane; Hoster Eva; Kehden Britta; Unterhalt Michael; Herold Michael; van der Jagt Richard; Janssens Ann; Kneba Michael; Mayer Jiri; Pocock Christopher; Knapp Andrea; Danesi Nathalie; Nielsen Tina; Brown Helen; Mundt Kirsten; Marcus Robert; Hiddemann Wolfgang;

  展开▼
• 作者单位

  Univ Hosp Schleswig Holstein Kiel Germany;

  Ludwig Maximilians Univ Hosp Dept Med 3 Munich Germany;

  Univ Hosp Schleswig Holstein Kiel Germany;

  Ludwig Maximilians Univ Hosp Dept Med 3 Munich Germany;

  HELIOS Klin Erfurt Germany;

  Ottawa Hosp Ottawa ON Canada;

  Univ Leuven Dept Oncol Leuven Belgium;

  Univ Hosp Schleswig Holstein Kiel Germany;

  Masaryk Univ Fac Med Dept Internal Med Hematol &

  Oncol Brno Czech Republic;

  East Kent Hosp Canterbury Kent England;

  F Hoffmann La Roche Ltd Basel Switzerland;

  F Hoffmann La Roche Ltd Basel Switzerland;

  F Hoffmann La Roche Ltd Basel Switzerland;

  Roche Prod Ltd Welwyn Garden City England;

  F Hoffmann La Roche Ltd Basel Switzerland;

  Kings Coll Hosp London London England;

  Univ Munich Univ Hosp Dept Med 3 Lab Leukemia Diagnost Munich Germany;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病 ;
• 关键词